Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment

IMPORTANCE: Cardiovascular events and mortality are the principal causes of excess mortality and health care costs for people with type 2 diabetes. No large studies have specifically compared long-acting insulin alone with long-acting plus short-acting insulin with regard to cardiovascular outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Emily B., Neugebauer, Romain, Reynolds, Kristi, Schmittdiel, Julie A., Loes, Linda, Dyer, Wendy, Pimentel, Noel, Desai, Jay R., Vazquez-Benitez, Gabriela, Ho, P. Michael, Anderson, Jeffrey P., O’Connor, Patrick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463942/
https://www.ncbi.nlm.nih.gov/pubmed/34559229
http://dx.doi.org/10.1001/jamanetworkopen.2021.26605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463942/
https://www.ncbi.nlm.nih.gov/pubmed/34559229
http://dx.doi.org/10.1001/jamanetworkopen.2021.26605

Ejemplares similares